Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual
暂无分享,去创建一个
E. G. Shpaer | B. Walker | M. Hirsch | T. Merigan | A. Rodrigo | J. Mullins | H. Sheppard | A. Iversen | M. Hirsch | Bruce D. Walker | Allen G. Rodrigo | Haynes W. Sheppard | Astrid K. N. Iversen | Martin S. Hirsch | Thomas C. Merigan | Andjames I. Mullins
[1] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[2] John W. Mellors,et al. Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences , 1997 .
[3] John L. Sullivan,et al. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .
[4] J. Margolick,et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. , 1995, The New England journal of medicine.
[5] D. Ho,et al. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.
[6] B. Walker,et al. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays , 1994, Journal of virology.
[7] S. Knapp,et al. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon , 1994, Journal of virology.
[8] Groen,et al. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate , 1994, Journal of virology.
[9] D. Baltimore,et al. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[10] L. Kingsley,et al. Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. , 1993, Virology.
[11] E. Vittinghoff,et al. The characterization of non‐progressors: long‐term HIV‐1 infection with stable CD4+ T‐cell levels , 1993, AIDS.
[12] B. Margolin,et al. V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability , 1993, Journal of virology.
[13] H. Schuitemaker,et al. Relation of phenotype evolution of HIV-1 to envelope V2 configuration. , 1993, Science.
[14] A. Osterhaus,et al. Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation , 1993, Journal of virology.
[15] J. Sodroski,et al. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody , 1993, Journal of virology.
[16] G. Pantaleo,et al. The RRE of human immunodeficiency virus type 1 contributes to cell-type-specific viral tropism , 1993, Journal of virology.
[17] J. Levy,et al. Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages , 1993, Journal of clinical microbiology.
[18] O. Bagasra,et al. Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Goudsmit,et al. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution , 1992, Journal of virology.
[20] D. Costagliola,et al. Towards a new predictor of AIDS progression through the quantisation of HIV‐1 DNA copies by PCR in HIV‐infected individuals , 1992, British journal of haematology.
[21] B. Cullen,et al. Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2 , 1992, Journal of virology.
[22] C. Kuiken,et al. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype , 1992, Journal of virology.
[23] H. Mitsuya,et al. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. , 1992, AIDS research and human retroviruses.
[24] H. Schuitemaker,et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.
[25] J. Sodroski,et al. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus , 1992, Journal of virology.
[26] J. Hauber,et al. Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange , 1992, Journal of virology.
[27] E. G. Shpaer,et al. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro , 1992, Journal of virology.
[28] R. Coutinho,et al. HIV‐1 biological phenotype in long‐term infected individuals evaluated with an MT‐2 cocultivation assay , 1992, AIDS.
[29] T. Hope,et al. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Malim,et al. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain , 1991, Journal of virology.
[31] J. Hauber,et al. trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences. , 1991, Virology.
[32] M. Malim,et al. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: Implications for HIV-1 latency , 1991, Cell.
[33] P. Sharp,et al. Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[34] H. Schuitemaker,et al. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture , 1991, Journal of virology.
[35] J. Sodroski,et al. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion , 1990, Journal of virology.
[36] D. Serwadda,et al. Nucleotide sequence of a Ugandan HIV-1 provirus reveals genetic diversity from other HIV-1 isolates. , 1990, AIDS research and human retroviruses.
[37] J. Mullins,et al. Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 , 1990, Nature.
[38] E. Freed,et al. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[39] E. Delwart,et al. Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat. , 1990, AIDS research and human retroviruses.
[40] S. Le,et al. A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. , 1990, Nucleic acids research.
[41] Bryan R. Cullen,et al. HIV-1 structural gene expression requires binding of the rev trans-activator to its RNA target sequence , 1990, Cell.
[42] R. Garry,et al. A general model for the transmembrane proteins of HIV and other retroviruses. , 1989, AIDS research and human retroviruses.
[43] M. Malim,et al. Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function , 1989, Cell.
[44] Lange,et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.
[45] B. Franza,et al. Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins , 1989, Journal of virology.
[46] G. Myers,et al. Molecular characterization of HIV-1 isolated from a serum collected in 1976: nucleotide sequence comparison to recent isolates and generation of hybrid HIV. , 1989, AIDS research and human retroviruses.
[47] F. Witney,et al. Efficient site-directed in vitro mutagenesis using phagemid vectors. , 1989, BioTechniques.
[48] M. Malim,et al. Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein , 1988, Nature.
[49] J. Jurka,et al. Multiple aligned sequence editor (MASE). , 1988, Trends in biochemical sciences.
[50] M. Reitz,et al. Envelope sequences of two new United States HIV-1 isolates. , 1988, Virology.
[51] Huisman,et al. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex , 1988, Journal of virology.
[52] C. Cheng‐Mayer,et al. Biologic features of HIV-1 that correlate with virulence in the host. , 1988, Science.
[53] Gilcher Ro. Human retroviruses and AIDS. , 1988 .
[54] J. Mullins,et al. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. , 1988, Science.
[55] M. Siekevitz,et al. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. , 1987, Science.
[56] J. Albert,et al. REPLICATIVE CAPACITY OF HUMAN IMMUNODEFICIENCY VIRUS FROM PATIENTS WITH VARYING SEVERITY OF HIV INFECTION , 1986, The Lancet.
[57] H. Gendelman,et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.
[58] R. Schooley,et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. , 1985, The New England journal of medicine.
[59] M. Hirsch,et al. Primary human T-lymphotropic virus type III infection. , 1985, Annals of internal medicine.
[60] K. Nilsson,et al. In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. , 1991, Journal of acquired immune deficiency syndromes.
[61] M. Popovič,et al. Virus Isolation and Production , 1990 .
[62] S. Ruben,et al. Structural and functional characterization of the human immunodeficiency virus rev protein. , 1989, Journal of acquired immune deficiency syndromes.
[63] R. Gilcher. Human retroviruses and AIDS. , 1988, The Journal of the Oklahoma State Medical Association.
[64] B. Seed. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2 , 1987, Nature.
[65] D. Salberg. Virologic studies in a case of transfusion-associated AIDS. , 1985, The New England journal of medicine.